Find a Viewpoint

Antimicrobial Viewpoints are articles in which experts in different areas of antimicrobial resistance share their knowledge and opinions about the current status and the future challenges of this field. You can read our editorial and ethics policies for these articles here

<br>Access to industry antimicrobial resistance (AMR) susceptibility surveillance data</br><em> – by Rebecca Li & Patricia Bradford</em>
25 January 2023

Access to industry antimicrobial resistance (AMR) susceptibility surveillance data – by Rebecca Li & Patricia Bradford

more
<br>Investing in the future of phage therapy</br><em> – by Jon Iredell & Jessica Sacher</em>
10 January 2023

Investing in the future of phage therapy – by Jon Iredell & Jessica Sacher

more
<br>Lack of access to generic antibiotics and antifungals is an overlooked issue in AMR</br><em> – by Fatema Rafiqi, Moska Hellamand and Martijn van Gerven </em>
17 October 2022

Lack of access to generic antibiotics and antifungals is an overlooked issue in AMR – by Fatema Rafiqi, Moska Hellamand and Martijn van ...

more
<br>Improving our ability to discover new antibiotics – a chemist’s overview</br><em> – by Mark Blaskovich</em>
25 August 2022

Improving our ability to discover new antibiotics – a chemist’s overview – by Mark Blaskovich

more
<br>Making matters worse: antimicrobial resistance in conflict settings</br><em> – by Jacob Goldberg, Angela Uyen-Cateriano and Gijs Van Gassen </em>
23 June 2022

Making matters worse: antimicrobial resistance in conflict settings – by Jacob Goldberg, Angela Uyen-Cateriano and Gijs Van Gassen

more
<br>Global antibiotic use patterns in children</br><em> – by Julia A. Bielicki and Victor Musiime</em>
27 April 2022

Global antibiotic use patterns in children – by Julia A. Bielicki and Victor Musiime

more

Share

FacebookTwitterLinkedInEmail
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top